Glycosaminoglycans and mucopolysaccharidosis type III

Joanna Jakóbkiewicz-Banecka , Magdalena Gabig-Cimińska , Anna Kloska , Marcelina Malinowska , Ewa Piotrowska , Zyta Banecka-Majkutewicz , Bogdan Banecki , Alicja Węgrzyn , Grzegorz Węgrzyn


Author Joanna Jakóbkiewicz-Banecka KBM
Joanna Jakóbkiewicz-Banecka,,
- Department of Molecular Biology
, Magdalena Gabig-Cimińska
Magdalena Gabig-Cimińska,,
, Anna Kloska KBiGM
Anna Kloska,,
- Katedra Biologii i Genetyki Medycznej
, Marcelina Malinowska KBiGM
Marcelina Malinowska,,
- Katedra Biologii i Genetyki Medycznej
, Ewa Piotrowska KBM
Ewa Piotrowska,,
- Department of Molecular Biology
, Zyta Banecka-Majkutewicz
Zyta Banecka-Majkutewicz,,
, Bogdan Banecki KBMiK
Bogdan Banecki,,
- Department of Molecular and Cellular Biology
, Alicja Węgrzyn
Alicja Węgrzyn,,
, Grzegorz Węgrzyn KBM
Grzegorz Węgrzyn,,
- Department of Molecular Biology
Journal seriesFrontiers in Bioscience-Landmark, ISSN 1093-9946
Issue year2016
Keywords in Englishmucopolysaccharidosis type III, Sanfilippo disease, heparan sulfate, enzyme replacement therapy, gene therapy and substrate reduction thearapy, review
Languageen angielski
Score (nominal)30
ScoreMinisterial score = 25.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 30.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2016 = 2.497 (2) - 2016=2.758 (5)
Citation count*0
Share Share

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.